Page 11 - 2018_12-Haematologica-web

haematologica Journal of the European Hematology Association
Published by the Ferrata Storti Foundation
e567 Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression Kevin Gaffney et al.
http://www.haematologica.org/content/103/12/e567
e571 The fetal liver lymphoid-primed multipotent progenitor provides the prerequisites for the initiation of t(4;11) MLL-AF4 infant leukemia Camille Malouf and Katrin Ottersbach
http://www.haematologica.org/content/103/12/e571
e575 A novel type of NPM1 mutation characterized by multiple internal tandem repeats in a case of cytogenetically normal acute myeloid leukemia
Nicolas Duployez et al. http://www.haematologica.org/content/103/12/e575
e578 Acute myeloid leukemia in very old patients Vladimir Lj Lazarevic et al.
http://www.haematologica.org/content/103/12/e578
e581 Relapse of acute myeloid leukemia after allogeneic stem cell transplantation is associated with gain of WT1 alterations and high mutation load
Sebastian Vosberg et al. http://www.haematologica.org/content/103/12/e581
e585 A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing
Karen Verboom et al. http://www.haematologica.org/content/103/12/e585
e590 Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD Diego Villa et al.
http://www.haematologica.org/content/103/12/e590
e594 Impact of Sox11 over-expression in Ba/F3 cells Martin Lord et al.
http://www.haematologica.org/content/103/12/e594
e598 Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia Silvia Martinelli et al.
http://www.haematologica.org/content/103/12/e598
e602 Treatment optimization for multiple myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in in vitro and ex vivo models
Enrica Borsi et al. http://www.haematologica.org/content/103/12/e602
Case Reports
Case Reports are available online only at www.haematologica.org/content/103/12.toc
e607 Somatic reversion events point towards RPL4 as a novel disease gene in a condition resembling Diamond-Blackfan anemia Marjolijn C. J. Jongmans et al.
http://www.haematologica.org/content/103/12/e607
e610 Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis Carlo O. Martins et al.
http://www.haematologica.org/content/103/12/e610
e613 A mutation in the gene coding for the sialic acid transporter SLC35A1 is required for platelet life span but not proplatelet formation Alexandre Kauskot et al.
http://www.haematologica.org/content/103/12/e613
Haematologica 2018; vol. 103 no. 12 - December 2018 http://www.haematologica.org/